Signaling via the TGFβ pathway is essential in cellular differentiation, apoptosis, invasion, angiogenesis and immune regulation and dysregulation in this pathway is established in ovarian cancer tumorigenesis and progression, revealing therapeutic targets that have been explored (49). This evidence concerns the gene TGFB1 and ovarian carcinoma.